Diabetics will now see a break in their out-of-pocket costs for insulin. Sanofi, one of the leading manufacturers of the hormone, joined two other major pharmaceutical companies in capping their insulin copays at $35. This comes after years of pressure by President Biden, lawmakers and activists for companies to lower their list prices. White House Correspondent Laura Barrón-López reports.
KFOR is hearing from the Oklahoma Attorney General one day after he announced possible legal action over inflated prices of insulin. He believes it has been potentially affecting hundreds of thousands of Oklahomans.